Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POP-LOOP: Closed-loop Insulin in Perioperative T2D
NCT04361799Completed
- Sponsor
- Insel Gruppe
- Start
- Sep 2020
- Primary completion
- Sep 2021
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Insel Gruppe. Primary endpoint: Proportion of time spent in the target glucose range (5.6 to 10.0 mmol/L) up to 20 days. Started Sep 2020; status: completed.
Beyond the preview
Go deeper on NCT04361799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04361799.